Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
135.8 USD | -1.44% | +1.56% | +79.66% |
Jun. 07 | The job report just threw a spanner in the works | |
Jun. 07 | ANALYST RECOMMENDATIONS : Lyft, Amazon, Fedex, Xpo, Unilever... |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 4.94 for the current year.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+79.66% | 13.46B | C+ | ||
+24.25% | 89.38B | C+ | ||
-24.01% | 75.67B | B- | ||
+6.34% | 28.83B | C+ | ||
+4.85% | 18.25B | A- | ||
-13.14% | 16.51B | B | ||
+2.09% | 15.72B | A- | ||
+79.55% | 13.71B | C- | ||
+21.81% | 12.64B | B- | ||
+33.51% | 12.42B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- THC Stock
- Ratings Tenet Healthcare Corporation